Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02404207 · ClinicalTrials.gov registry record · NA

Soybean Oil Trial of cArdiovascular Risk

A NA study of Diabetes and Cardiovascular Disease, sponsored by USDA Beltsville Human Nutrition Research Center.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02404207 is a NA study of Diabetes and Cardiovascular Disease that has completed, run by USDA Beltsville Human Nutrition Research Center. The registered enrollment target is 60 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02404207, a NA study of Diabetes and Cardiovascular Disease, has completed, sponsored by USDA Beltsville Human Nutrition Research Center.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The study will determine the effects of different types of soybean oils on biomarkers of risk for cardiovascular disease and diabetes. There will be four 4-week diet periods in which participants will consume the following oils, within the context of a controlled diet: soybean oil, high-oleic soybean oil, blend of high oleic soybean oil \& fully hydrogenated soybean oil, and blend of palm olein \& palm stearin.

Interventions

  • OTHER Soybean oil
  • OTHER High-oleic soybean oil
  • OTHER High-oleic soybean oil + fully hydrogenated soybean oil
  • OTHER Palm olein + palm stearin

Study Locations (1)

Maryland

  • USDA-ARS, Beltsville Human Nutrition Research Center - Beltsville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2015-03
Est. Completion 2015-10
Phase NA

What the Registry Record Tells You About NCT02404207

The ClinicalTrials.gov registry entry for NCT02404207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is USDA Beltsville Human Nutrition Research Center, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Diabetes appearing as the primary indexed condition, and to 4 interventions - of which Soybean oil is the first listed.

NCT02404207 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02404207 about?

NCT02404207 is a clinical study titled "Soybean Oil Trial of cArdiovascular Risk". The study will determine the effects of different types of soybean oils on biomarkers of risk for cardiovascular disease and diabetes. There will be four 4-week diet periods in which participants will consume the following oils, within the context of a controlled diet: soybean oil, high-oleic soybea...

What is the current status of trial NCT02404207?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-03. Estimated completion is 2015-10.

What conditions does trial NCT02404207 study?

This clinical trial studies the following conditions: Diabetes, Cardiovascular Disease, Metabolic Syndrome.

What interventions are being tested in trial NCT02404207?

The interventions under investigation include: Soybean oil (OTHER), High-oleic soybean oil (OTHER), High-oleic soybean oil + fully hydrogenated soybean oil (OTHER), Palm olein + palm stearin (OTHER).

Who is sponsoring clinical trial NCT02404207?

This trial is sponsored by USDA Beltsville Human Nutrition Research Center, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02404207 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.